- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2206443 58 comments science
Linking pages
- Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2109522 1533 comments
- MDMA, psilocybin approved for psychiatric use in Australia https://www.watoday.com.au/politics/federal/australia-becomes-first-country-to-recognise-psychedelics-as-medicines-20230203-p5chs6.html 164 comments
- Magic-mushroom drug can treat severe depression, trial suggests - BBC News https://www.bbc.co.uk/news/health-63475630 135 comments
- An Unconscious Patient with a DNR Tattoo | NEJM http://www.nejm.org/doi/full/10.1056/NEJMc1713344 100 comments
- Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2201662 94 comments
- What If Psychedelics' Hallucinations Are Just a Side Effect? - The Atlantic https://www.theatlantic.com/health/archive/2023/11/non-hallucinogenic-psychedelic-clinical-therapy/675942/ 76 comments
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2109072 56 comments
- MDMA, psilocybin approved by TGA for psychiatric use in Australia https://www.smh.com.au/politics/federal/australia-becomes-first-country-to-recognise-psychedelics-as-medicines-20230203-p5chs6.html 54 comments
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2108891 50 comments
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM https://www.nejm.org/doi/10.1056/NEJMc2101667 23 comments
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome | NEJM http://www.nejm.org/doi/full/10.1056/NEJMoa1611618 20 comments
- Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2118946 18 comments
- Effect of Early Treatment with Ivermectin among Patients with Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 14 comments
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2020283?query=featured_home 10 comments
- Scientists Now Know Why Psychedelics Conquer Depression Even Without a High https://singularityhub.com/2023/06/06/psychedelic-inspired-drugs-could-beat-depression-without-the-trip/ 8 comments
- Effect of Abuse-Deterrent Formulation of OxyContin | NEJM http://www.nejm.org/doi/full/10.1056/nejmc1204141 4 comments
- How Well Do Antidepressants Work and What Are Alternatives? - The New York Times https://www.nytimes.com/2022/11/08/well/mind/antidepressants-effects-alternatives.html 4 comments
- Atogepant for the Preventive Treatment of Migraine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2035908 3 comments
- Universal Screening for SARS-CoV-2 in Women Admitted for Delivery | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2009316 2 comments
- Could 'magic mushrooms' treat severe depression? A major study aims to find out. https://www.nbcnews.com/health/health-news/magic-mushrooms-treat-severe-depression-major-study-aims-find-rcna54856 2 comments
Related searches:
Search whole site: site:doi.org
Search title: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM
See how to search.